acetylleucine 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
71 99-15-0

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • acetylleucine
  • (S)-2-Acetamido-4-methylpentanoic acid
  • Acetyl-L-leucine
  • N-Acetylleucine
used for treating vestibular-related imbalance and vertigo
  • Molecular weight: 173.21
  • Formula: C8H15NO3
  • CLOGP: 0.86
  • LIPINSKI: 0
  • HAC: 4
  • HDO: 2
  • TPSA: 66.40
  • ALOGS: -1.20
  • ROTB: 4

Drug dosage:

None

ADMET properties:

None

Approvals:

None

FDA Adverse Event Reporting System (Female)

None

FDA Adverse Event Reporting System (Male)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Anticoagulation drug level above therapeutic 75.32 69.12 14 377 1817 29572319

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Hepatitis acute 67.40 48.92 18 752 13371 64484591
Anticoagulation drug level above therapeutic 63.58 48.92 13 757 3032 64494930
Haematoma 59.92 48.92 22 748 46228 64451734

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
ATC N07CA04 NERVOUS SYSTEM
OTHER NERVOUS SYSTEM DRUGS
ANTIVERTIGO PREPARATIONS
Antivertigo preparations
CHEBI has role CHEBI:25212 metabolites

Drug Use | Suggest Off label Use Form| |View source of the data|

None




🐶 Veterinary Drug Use

None

🐶 Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 3.9 acidic
pKa2 13.57 acidic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

None

Bioactivity Summary:

None

External reference:

IDSource
D07350 KEGG_DRUG
C0256552 UMLSCUI
CHEBI:166830 CHEBI
CHEMBL1875805 ChEMBL_ID
DB13226 DRUGBANK_ID
CHEMBL56021 ChEMBL_ID
70912 PUBCHEM_CID
5209 INN_ID
C088117 MESH_SUPPLEMENTAL_RECORD_UI
K76S41V71X UNII
005881 NDDF
735136009 SNOMEDCT_US

Pharmaceutical products:

None